Trees D L, Spinola S M
Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill.
J Infect Dis. 1990 Feb;161(2):336-9. doi: 10.1093/infdis/161.2.336.
The development of vaccines to prevent Neisseria infections has been impeded by antigenic diversity of most Neisseria surface components. The lipid-modified azurin (Laz), one of two distinct surface proteins recognized by the H.8 monoclonal antibody, is present in all pathogenic Neisseria. The mature protein has two domains; one contains an H.8 epitope and the other has extensive homology to azurins, a class of bacterial copper-binding proteins. The cellular location of Laz and the serum immune response to Lax were examined in patients with disseminated Neisseria infections. The data demonstrated that Laz is probably contained in the Neisseria outer membrane, although unlike most outer membrane proteins it is Sarkosyl soluble. By probing recombinant bacteriophages encoding the H.8 and azurin domains of Laz, results showed that whereas the H.8 epitope is immunogenic in patients with disseminated Neisseria infections, the azurin domain of Laz plays little role in eliciting an antibody response in these patients.
大多数奈瑟菌表面成分的抗原多样性阻碍了预防奈瑟菌感染疫苗的研发。脂质修饰天青蛋白(Laz)是H.8单克隆抗体识别的两种不同表面蛋白之一,存在于所有致病性奈瑟菌中。成熟蛋白有两个结构域;一个包含H.8表位,另一个与天青蛋白(一类细菌铜结合蛋白)有广泛的同源性。对播散性奈瑟菌感染患者的Laz细胞定位和针对Laz的血清免疫反应进行了研究。数据表明,Laz可能存在于奈瑟菌外膜中,尽管与大多数外膜蛋白不同,它可溶于十二烷基肌氨酸钠。通过探测编码Laz的H.8和天青蛋白结构域的重组噬菌体,结果显示,虽然H.8表位在播散性奈瑟菌感染患者中具有免疫原性,但Laz的天青蛋白结构域在引发这些患者的抗体反应中作用不大。